TY - JOUR AU - Chamberlain, A. M. AU - Schabath, M. B. AU - Folson, A. R. PY - 2009 DA - 2009// TI - Associations of chronic obstructive pulmonary disease with all-cause mortality in Blacks and Whites: the atherosclerosis risk in communities (ARIC) study JO - Ethn Dis VL - 19 ID - Chamberlain2009 ER - TY - JOUR AU - Ekberg-Aronsson, M. AU - Pehrsson, K. AU - Nilsson, J. A. AU - Nilsson, P. M. AU - Löfdahl, C. G. PY - 2005 DA - 2005// TI - Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis JO - Respir Res VL - 6 UR - https://doi.org/10.1186/1465-9921-6-98 DO - 10.1186/1465-9921-6-98 ID - Ekberg-Aronsson2005 ER - TY - JOUR PY - 2000 DA - 2000// TI - Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease JO - N Engl J Med VL - 343 UR - https://doi.org/10.1056/NEJM200012283432601 DO - 10.1056/NEJM200012283432601 ID - ref3 ER - TY - JOUR AU - Pauwels, R. A. AU - Löfdahl, C. G. AU - Laitinen, L. A. AU - Schouten, J. P. AU - Postma, D. S. AU - Pride, N. B. AU - Ohlsson, S. V. PY - 1999 DA - 1999// TI - Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking JO - N Engl J Med VL - 340 UR - https://doi.org/10.1056/NEJM199906243402503 DO - 10.1056/NEJM199906243402503 ID - Pauwels1999 ER - TY - JOUR AU - Calverley, P. M. AU - Boonsawat, W. AU - Cseke, Z. AU - Zhong, N. AU - Peterson, S. AU - Olsson, H. PY - 2003 DA - 2003// TI - Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease JO - Eur Respir J VL - 22 UR - https://doi.org/10.1183/09031936.03.00027003 DO - 10.1183/09031936.03.00027003 ID - Calverley2003 ER - TY - JOUR AU - Calverley, P. AU - Pauwels, R. AU - Vestbo, J. AU - Jones, P. AU - Pride, N. AU - Gulsvik, A. AU - Anderson, J. AU - Maden, C. PY - 2003 DA - 2003// TI - Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease:a randomised controlled trial JO - Lancet VL - 361 UR - https://doi.org/10.1016/S0140-6736(03)12459-2 DO - 10.1016/S0140-6736(03)12459-2 ID - Calverley2003 ER - TY - JOUR AU - Szafranski, W. AU - Cukier, A. AU - Ramirez, A. AU - Menga, G. AU - Sansores, R. AU - Nahabedian, S. AU - Peterson, S. AU - Olsson, H. PY - 2003 DA - 2003// TI - Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease JO - Eur Respir J VL - 21 UR - https://doi.org/10.1183/09031936.03.00031402 DO - 10.1183/09031936.03.00031402 ID - Szafranski2003 ER - TY - JOUR AU - Calverley, P. M. AU - Anderson, J. A. AU - Celli, B. AU - Ferguson, G. T. AU - Jenkins, C. AU - Jones, P. W. AU - Yates, J. C. AU - Vestbo, J. PY - 2007 DA - 2007// TI - Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa063070 DO - 10.1056/NEJMoa063070 ID - Calverley2007 ER - TY - STD TI - Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2010). [http://www.goldcopd.org/] UR - http://www.goldcopd.org/ ID - ref9 ER - TY - JOUR AU - Salpeter, S. R. AU - Buckley, N. S. AU - Salpeter, E. E. PY - 2006 DA - 2006// TI - Meta-analysis: anticholinergics, but not β-agonists, reduce severe exacerbations and respiratory mortality JO - Int J COPD VL - 21 ID - Salpeter2006 ER - TY - JOUR AU - Rodrigo, G. J. AU - Nannini, L. J. AU - Rodriguez-Roisin, R. PY - 2008 DA - 2008// TI - Safety of long-acting β-agonists in stable COPD: a systematic review JO - Chest VL - 133 UR - https://doi.org/10.1378/chest.07-1167 DO - 10.1378/chest.07-1167 ID - Rodrigo2008 ER - TY - JOUR AU - Campbell, M. AU - Eliraz, A. AU - Johansson, G. AU - Tornling, G. AU - Nihlén, U. AU - Bengtsson, T. AU - Rabe, K. PY - 2005 DA - 2005// TI - Formoterol for maintenance and as-needed treatment of chronic obstructive pulmonary disease JO - Respir Med VL - 99 UR - https://doi.org/10.1016/j.rmed.2005.08.016 DO - 10.1016/j.rmed.2005.08.016 ID - Campbell2005 ER - TY - JOUR AU - Jones, P. W. PY - 2002 DA - 2002// TI - Interpreting thresholds for a clinically significant change in health status in asthma and COPD JO - Eur Respir J VL - 19 UR - https://doi.org/10.1183/09031936.02.00063702 DO - 10.1183/09031936.02.00063702 ID - Jones2002 ER - TY - JOUR AU - Nelson, H. S. AU - Weiss, S. T. AU - Bleecker, E. T. AU - Yancey, S. W. AU - Dorinsky, P. M. PY - 2006 DA - 2006// TI - The Salmeterol Multicenter Asthma Research Trial JO - Chest VL - 129 UR - https://doi.org/10.1378/chest.129.1.15 DO - 10.1378/chest.129.1.15 ID - Nelson2006 ER - TY - JOUR AU - Benhamou, D. AU - Cuvelier, A. AU - Muir, J. F. AU - Leclerc, V. AU - Le Gros, V. AU - Kottakis, J. AU - Bourdeix, I. PY - 2001 DA - 2001// TI - Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil Aerolizer) with salbutamol (Ventodisk) JO - Respir Med VL - 95 UR - https://doi.org/10.1053/rmed.2001.1161 DO - 10.1053/rmed.2001.1161 ID - Benhamou2001 ER - TY - JOUR AU - Bouros, D. AU - Kottakis, J. AU - Le Gros, V. AU - Overend, T. AU - Della Cioppa, G. AU - Siafakas, N. PY - 2004 DA - 2004// TI - Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV(1) reversibility JO - Curr Med Res Opin VL - 20 UR - https://doi.org/10.1185/030079904125003368 DO - 10.1185/030079904125003368 ID - Bouros2004 ER - TY - JOUR AU - Dahl, R. AU - Greefhorst, L. A. AU - Nowak, D. AU - Nonikov, V. AU - Byrne, A. M. AU - Thomson, M. H. AU - Till, D. AU - Della Cioppa, G. PY - 2001 DA - 2001// TI - Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med VL - 164 UR - https://doi.org/10.1164/ajrccm.164.5.2007006 DO - 10.1164/ajrccm.164.5.2007006 ID - Dahl2001 ER - TY - JOUR AU - Di Marco, F. AU - Verga, M. AU - Santus, P. AU - Morelli, N. AU - Cazzola, M. AU - Centanni, S. PY - 2006 DA - 2006// TI - Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation on chronic obstructive pulmonary disease: a pilot study JO - Respir Med VL - 100 UR - https://doi.org/10.1016/j.rmed.2006.03.007 DO - 10.1016/j.rmed.2006.03.007 ID - Di Marco2006 ER - TY - JOUR AU - Maesen, B. L. AU - Westermann, C. J. AU - Duurkens, V. A. AU - van den Bosch, J. M. PY - 1999 DA - 1999// TI - Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease JO - Eur Respir J VL - 13 UR - https://doi.org/10.1034/j.1399-3003.1999.13e27.x DO - 10.1034/j.1399-3003.1999.13e27.x ID - Maesen1999 ER - TY - JOUR AU - Rossi, A. AU - Kristufek, P. AU - Levine, B. E. AU - Thomson, M. H. AU - Till, D. AU - Kottakis, J. AU - Della Cioppa, G. PY - 2002 DA - 2002// TI - Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD JO - Chest VL - 121 UR - https://doi.org/10.1378/chest.121.4.1058 DO - 10.1378/chest.121.4.1058 ID - Rossi2002 ER - TY - JOUR AU - Kottakis, J. AU - Cioppa, G. D. AU - Creemers, J. AU - Greefhorst, L. AU - Lecler, V. AU - Pistelli, R. AU - Overend, T. AU - Till, D. AU - Rapatz, G. AU - Le Gros, V. AU - Bouros, D. AU - Siafakas, N. PY - 2002 DA - 2002// TI - Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: results of a randomized, double-blind clinical study JO - Can Respir J VL - 9 UR - https://doi.org/10.1155/2002/604092 DO - 10.1155/2002/604092 ID - Kottakis2002 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2466/11/51/prepub UR - http://www.biomedcentral.com/1471-2466/11/51/prepub ID - ref22 ER -